Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer

Go back to Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer
(NASDAQ: RPHM) Delayed: 1.82 --0 (-0%)
Previous Close $1.82    52 Week High
Open $1.82    52 Week Low
Day High $1.82    P/E N/A 
Day Low $1.82    EPS
Volume 76,700